Skip to main content
SpringerLink
Log in

Inhalation im Kindesalter

Inhalation therapy in children

  • Pädiatrische Pneumologie
  • Published:
Der Pneumologe Aims and scope

Zusammenfassung

In der Behandlung von Kindern mit obstruktiven Atemwegserkrankungen erfolgt die Applikation von Arzneistoffen überwiegend als inhalative Therapie. Dies bietet eine Reihe von Vorteilen gegenüber einer systemischen Therapie wie geringere Nebenwirkungen und schnelleren Wirkungseintritt. Die effektive Nutzung hängt jedoch entscheidend vom Inhalationsgerät und der Fähigkeit des Patienten ab, das System korrekt zu verwenden. Dieser Artikel stellt eine Übersicht möglicher Geräte und Medikamente zusammen, zählt häufige Anwendungsfehler auf und bietet Lösungen an, um eine optimale Therapie zu gewährleisten.

Abstract

In the treatment of children with obstructive pulmonary disease, the application of drugs is mainly in form of an inhaled therapy. This offers a number of advantages compared to systemic therapy, with fewer side effects and faster onset of reaction. The efficient use depends crucially on the inhaler and the patient’s ability to use the system properly. This article compiles a list of possible devices and drugs, summarizes frequent application errors and offers solutions to ensure optimal treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Amin R, Subbarao P, Jabar A et al (2010) Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 65:379–383

    Article  PubMed  Google Scholar 

  2. Amin R, Subbarao P, Lou W et al (2011) The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur Respir J 37:806–812

    Article  PubMed  CAS  Google Scholar 

  3. Assael BM (2011) Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Expert Rev Anti Infect Ther 9:967–973

    Article  PubMed  CAS  Google Scholar 

  4. Ater D, Shai H, Bar BE et al (2012) Hypertonic saline and acute wheezing in preschool children. Pediatrics 129:e1397–e1403

    Article  PubMed  Google Scholar 

  5. Basheti IA, Armour CL, Reddel HK et al (2009) Long-term maintenance of pharmacists‘ inhaler technique demonstration skills. Am J Pharm Educ 73:32

    Article  PubMed  Google Scholar 

  6. Brand PL (2005) Key issues in inhalation therapy in children. Curr Med Res Opin 21(Suppl 4):27–32

    Article  Google Scholar 

  7. Capstick TG, Clifton IJ (2012) Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir Med 6:91–101 (quiz 102–103)

    Article  PubMed  CAS  Google Scholar 

  8. Coates AL, Denk O, Leung K et al (2011) Higher tobramycin concentration and vibrating mesh technology can shorten antibiotic treatment time in cystic fibrosis. Pediatr Pulmonol 46:401–408

    Article  PubMed  Google Scholar 

  9. Daviskas E, Anderson SD, Jaques A et al (2010) Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis. Chest 137:861–868

    Article  PubMed  CAS  Google Scholar 

  10. Deerojanawong J, Manuyakorn W, Prapphal N et al (2005) Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing. Pediatr Pulmonol 39:466–472

    Article  PubMed  CAS  Google Scholar 

  11. Donaldson SH, Bennett WD, Zeman KL et al (2006) Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 354:241–250

    Article  PubMed  CAS  Google Scholar 

  12. Elkins MR, Robinson M, Rose BR et al (2006) A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 354:229–240

    Article  PubMed  CAS  Google Scholar 

  13. Fink JB, Rubin BK (2005) Problems with inhaler use: a call for improved clinician and patient education. Respir Care 50:1360–1374 (discussion 1374–1365)

    PubMed  Google Scholar 

  14. Hoffmann IM, Rubin BK, Iskandar SS et al (2002) Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy. Pediatr Pulmonol 34:375–377

    Article  PubMed  Google Scholar 

  15. Kamps AW, Van Ewijk B, Roorda RJ et al (2000) Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr Pulmonol 29:39–42

    Article  PubMed  CAS  Google Scholar 

  16. Kelly HW, Sternberg AL, Lescher R et al (2012) Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 367:904–912

    Article  PubMed  CAS  Google Scholar 

  17. Labiris NR, Dolovich MB (2003) Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 56:588–599

    Article  PubMed  CAS  Google Scholar 

  18. Laube BL, Janssens HM, De Jongh FH et al (2011) What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 37:1308–1331

    Article  PubMed  CAS  Google Scholar 

  19. Lavorini F, Magnan A, Dubus JC et al (2008) Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 102:593–604

    Article  PubMed  Google Scholar 

  20. Leung K, Louca E, Coates AL (2004) Comparison of breath-enhanced to breath-actuated nebulizers for rate, consistency, and efficiency. Chest 126:1619–1627

    Article  PubMed  Google Scholar 

  21. Lewis RM, Fink JB (2001) Promoting adherence to inhaled therapy: building partnerships through patient education. Respir Care Clin N Am 7:277–301, vi

    Article  PubMed  CAS  Google Scholar 

  22. Mallol J, Rattray S, Walker G et al (1996) Aerosol deposition in infants with cystic fibrosis. Pediatr Pulmonol 21:276–281

    Article  PubMed  CAS  Google Scholar 

  23. Melani AS (2007) Inhalatory therapy training: a priority challenge for the physician. Acta Biomed 78:233–245

    PubMed  Google Scholar 

  24. Pierart F, Wildhaber JH, Vrancken I et al (1999) Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J 13:673–678

    Article  PubMed  CAS  Google Scholar 

  25. Price D, Chrystyn H, Kaplan A et al (2012) Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care. Allergy Asthma Immunol Res 4:184–191

    Article  PubMed  CAS  Google Scholar 

  26. Rubin BK (2010) Air and soul: the science and application of aerosol therapy. Respir Care 55:911–921

    PubMed  Google Scholar 

  27. Rubin BK (2011) Pediatric aerosol therapy: new devices and new drugs. Respir Care 56:1411–1421 (discussion 1421–1413)

    Article  PubMed  Google Scholar 

  28. Sanders M (2007) Inhalation therapy: an historical review. Prim Care Respir J 16:71–81

    Article  PubMed  Google Scholar 

  29. Sauvaget E, David M, Bresson V et al (2012) Nebulized hypertonic saline and acute viral bronchiolitis in infants: current aspects. Arch Pediatr 19:635–641

    PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist für sich und seine Koautoren auf folgende Beziehung hin: M.V. Kopp ist im Advisory-Board „Xolair“ der Firma Novartis GmbH und hat Vortragshonorare von den Firmen Novartis GmbH, Chiesi GmbH, GlaxoSmithKline GmbH und Nestle Health Care Nutrition erhalten.

Author information

Authors and Affiliations

  1. Klinik für Kinder- und JugendmedizinSchwerpunkt Kinderpneumologie und Allergologie, Universität Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland

    T. Weisner & M.V. Kopp

  2. Airway Research Centre North (ARCN), German Center for Lung Research (DZL), Lübeck, Deutschland

    T. Weisner & M.V. Kopp

Authors
  1. T. Weisner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.V. Kopp
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Weisner.

Additional information

Principal investigator in the Airway Research Centre North (ARCN), Member of the German Center for Lung Research (DZL).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weisner, T., Kopp, M. Inhalation im Kindesalter. Pneumologe 10, 126–133 (2013). https://doi.org/10.1007/s10405-013-0669-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-013-0669-4

Schlüsselwörter

Keywords

Search

Navigation